FDA clears two Scientia Vascular catheters
Scientia Vascular today announced it received FDA clearance for its two catheters, Plato 17 and Socrates 38.
Stay updated with breaking news from Scientia Vascular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientia Vascular today announced it received FDA clearance for its two catheters, Plato 17 and Socrates 38.
WEST VALLEY CITY, UT / ACCESSWIRE / February 21, 2024 / Scientia Vascular, an emerging company in the neurovascular medical technology sector, is proud to announce the promotion of Paul Fischer to Chief Commercial Officer amidst a phase of commercial success and corporate growth. Paul Fischer, Chief Commercial Offi...
Scientia Vascular Appoints Paul Fischer as Chief Commercial Officer ...
Scientia Vascular has raised $50M of growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!